Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

CWD Answers

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
Donate to CWD
Search for:
Contact Us

Archives

Research News

advertisement

November 17, 2015

Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies.
Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution. Free full text available in HTML and PDF formats.
Coxsackievirus B5 Infection Induces Dysregulation of MicroRNAs Predicted to Target Known Type 1 Diabetes Risk Genes in Human Pancreatic Islets.
Changing the Course of Disease in Type 1 Diabetes. Free full text available in HTML Reader format.
No association between use of multivitamin supplement containing vitamin D during pregnancy and risk of Type 1 Diabetes in the child.
Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island. Free full text available in HTML and PDF formats.
Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 Diabetes.
Protocol for systematic review of evidence on the determinants and influence of early glycaemic control in childhood-onset type 1 diabetes. Free full text available in HTML and PDF formats.
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. See also Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy.

November 11, 2015

Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. Free full text available in HTML and PDF via link (free membership required for access to PDF). See also A Glimpse of Microbial Power in Preventive Medicine and Infants at Risk of Type 1 Diabetes Benefit from Early Probiotics.
A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas. Free full text available in HTML and PDF formats.
Postprandial capillary-venous glucose gradient in Type 1 diabetes: magnitude and clinical associations in a real-world setting.
Evaluation of the Average Daily Risk Range as a Measure of Glycemic Variability in Youths with Type 1 Diabetes.
Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas. Free full text available in HTML and PDF formats.
Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity.
Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy. Free full text available in HTML and PDF formats.

November 4, 2015

Single- and Dual-hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy.
Efficacy and Safety of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, as Add-On to Insulin in Patients With Type 1 Diabetes.
Variations in brain volume and growth in young children with type 1 diabetes.
Gestational Age and Birth Weight and the Risk of Childhood Type 1 Diabetes: A Population-Based Cohort and Sibling Design Study.
Vitamin D fortification and seasonality of birth in type 1 diabetic cases: D-tect study.

October 27, 2015

Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring.
Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.
Rapidly rising incidence of Type 1 diabetes in children and adolescents aged 0-19 years in Zhejiang, China, 2007 to 2013.

October 21, 2015

Towards an Earlier and Timely Diagnosis of Type 1 Diabetes: Is it Time to Change Criteria to Define Disease Onset?
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus.
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes.

October 14, 2015

Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays.
Genetic sharing and heritability of paediatric age of onset autoimmune diseases. Free full text available in PDF format.

October 7, 2015

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles.
Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes.
Development of a Smartphone Application to Capture Carbohydrate, Lipid, and Protein Contents of Daily Food: Need for Integration in Artificial Pancreas for Patients With Type 1 Diabetes?
Type 1 diabetes prevention: Insulin vaccine undergoes second trial.

September 30, 2015

Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report. Free full text available in PDF format.
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Free full text available in PDF format.
American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiom.
Alternate Approaches for Pediatric Type 1 Diabetes Drug Development and Potential Regulatory Approval: A Perspective. Free full text available in PDF format.
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study. Free full text available in HTML and PDF formats.
Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.
Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes.
Long-term function of alginate encapsulated islets.

September 23, 2015

Home Use of an Artificial Beta Cell in Type 1 Diabetes. Free full text available in PDF format.
Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System’s Fuzzy Logic Controller.
Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.
Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes.
EASD: Intranasal glucagon reverses hypoglycemia in children and adolescents.
Efficacy and safety of canagliflozin: results of an 18-week phase 2 study in patients with type 1 diabetes. See also Invokana lowers HbA1c and aids weight loss in adults with type 1 diabetes, study finds and First Data on SGLT2 Inhibitor Canagliflozin in Type 1 Diabetes.
Update on ketoacidosis with SGLT2 inhibitors.

September 18, 2015

Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration and selected gut bacteria.
Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial.

« Previous
1
…
37
38
39
40
41
…
94
Next »

advertisement

Last Updated: Thursday, June 12, 2025 09:12:22 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Email
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.